{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:32Z","timestamp":1788825632709,"version":"build-2803163510"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Progesterone (Pg) and estrogen (E) receptors (PgRs and ERs) are expressed in normal and neoplastic adrenal cortex, but their role is not fully understood. In literature, Pg demonstrated cytotoxic activity on AdrenoCortical Carcinoma (ACC) cells, while tamoxifen is cytotoxic in NCI-H295R cells. Here, we demonstrated that in ACC cell models, ERs were expressed in NCI-H295R cells with a prevalence of ER-<jats:italic>\u03b2<\/jats:italic> over the ER-<jats:italic>\u03b1<\/jats:italic>.Metastasis-derived MUC-1 and ACC115m cells displayed a very weak ER-<jats:italic>\u03b1<\/jats:italic>\/<jats:italic>\u03b2<\/jats:italic> signal, while PgR cells were expressed, although at low level. Accordingly, these latter were resistant to the SERM tamoxifen and scarcely sensitive to Pg, as we observed a lower potency compared to NCI-H295R cells in cytotoxicity (IC<jats:sub>50<\/jats:sub>: MUC-1 cells: 67.58 \u00b5M (95%CI: 63.22\u201373.04), ACC115m cells: 51.76 \u00b5M (95%CI: 46.45\u201357.67) and cell proliferation rate. Exposure of NCI-H295R cells to tamoxifen induced cytotoxicity (IC<jats:sub>50<\/jats:sub>: 5.43 \u00b5M (95%CI: 5.18\u20135.69 \u00b5M) mainly involving ER-<jats:italic>\u03b2<\/jats:italic>, as their nuclear localization increased after tamoxifen: \u0394 A.U. treated <jats:italic>vs<\/jats:italic> untreated: 12\u00a0h: +27.04% (p &amp;lt; 0.01); 24\u00a0h: +36.46% (p &amp;lt; 0.0001). This effect involved the SF-1 protein reduction: Pg: \u221236.34 \u00b1 9.26%; tamoxifen: \u221246.25 \u00b1 15.68% (p\u00a0&amp;lt; 0.01). Finally, in a cohort of 36 ACC samples, immunohistochemistry showed undetectable\/low level of ERs, while PgR demonstrated a higher expression. In conclusion, ACC experimental cell models expressed PgR and low levels of ER in line with data obtained in patient tissues, thus limiting the possibility of a clinical approach targeting ER. Interestingly, Pg exerted cytotoxicity also in metastatic ACC cells, although with low potency.<\/jats:p>","DOI":"10.3389\/fendo.2021.669426","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T11:16:14Z","timestamp":1619435774000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer"],"prefix":"10.3389","volume":"12","author":[{"given":"Elisa","family":"Rossini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Tamburello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Fragni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Cominelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Cosentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Hantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Bono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro Luigi","family":"Poliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido A. M.","family":"Tiberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Memo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Sigala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-013-0049-2","article-title":"Management of Adrenal Cancer: A 2013 Update","volume":"37","author":"Terzolo","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant Mitotane Treatment for Adrenocortical Carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2894","article-title":"Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma","volume":"102","author":"Berruti","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Esmo Guidelines Committee. Electronic Address: Clinicalguidelines@Esmo.Org. Adrenocortical Carcinomas and Malignant Phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200966","article-title":"Firm-Act Study Group. Combination Chemotherapy in Advanced Adrenocortical Carcinoma","volume":"66","author":"Fassnacht","year":"2012","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040941","article-title":"Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients With Advanced Adrenocortical Carcinoma: The Brescia Experience","volume":"12","author":"Lagan\u00e0","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0570","article-title":"Activity and Safety of Temozolomide in Advanced Adrenocortical Carcinoma Patients","volume":"181","author":"Cosentini","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0281","article-title":"Gemcitabine Plus Metronomic 5-Fluorouracil or Capecitabine as a Second-\/Third-Line Chemotherapy in Advanced Adrenocortical Carcinoma: A Multicenter Phase II Study","volume":"17","author":"Sperone","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6072863","article-title":"Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma","volume":"1","author":"Fiorentini","year":"2019","journal-title":"J Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0686","article-title":"The Long and Winding Road to Effective Immunotherapy in Patients With Adrenocortical Carcinoma","volume":"16","author":"Grisanti","year":"2020","journal-title":"Future Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-07-0081","article-title":"Expression of Progesterone and Estradiol Receptors in Normal Adrenal Cortex, Adrenocortical Tumors, and Primary Pigmented Nodular Adrenocortical Disease","volume":"15","author":"de Cremoux","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2329","article-title":"Identification and Developmental Changes of Aromatase and Estrogen Receptor Expression in Prepubertal and Pubertal Human Adrenal Tissues","volume":"92","author":"Baquedano","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0542-0","article-title":"Expression of Aromatase and Estrogen Receptors in Human Adrenocortical Tumors","volume":"452","author":"Barzon","year":"2008","journal-title":"Virchows Arch"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2018.01.004","article-title":"Bisphenol A Stimulates Adrenal Cortical Cell Proliferation Via Er\u03b2-Mediated Activation of the Sonic Hedgehog Signalling Pathway","volume":"178","author":"Medwid","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1631\/jzus.B0820072","article-title":"Estrogen Receptor Expression in Adrenocortical Carcinoma","volume":"10","author":"Shen","year":"2009","journal-title":"J Zhejiang Univ Sci B"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1677\/jme.1.01806","article-title":"Antiestrogens Upregulate Estrogen Receptor Beta Expression and Inhibit Adrenocortical H295R Cell Proliferation","volume":"35","author":"Montanaro","year":"2005","journal-title":"J Mol Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e003","DOI":"10.1621\/nrs.06003","article-title":"Estrogen Receptor \u00df: An Overview and Update","volume":"6","author":"Zhao","year":"2008","journal-title":"Nucl Recept Signal"},{"key":"B18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s12020-018-1795-x","article-title":"In Vitro Antitumor Activity of Progesterone in Human Adrenocortical Carcinoma","volume":"63","author":"Fragni","year":"2019","journal-title":"Endocrine"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/endo-126-2-891","article-title":"Multihormonal Regulation of the Progesterone Receptor in MCF-7 Human Breast Cancer Cells: Interrelationships Among Insulin\/Insulin-Like Growth factor-I, Serum, and Estrogen","volume":"126","author":"Katzenellenbogen","year":"1990","journal-title":"Endocrinology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(84)90187-x","article-title":"Tamoxifen and Endometrial Carcinoma: Alterations in Estrogen and Progesterone Receptors in Untreated Patients and Combination Hormonal Therapy in Advanced Neoplasia","volume":"149","author":"Carlson","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1530\/EJE-10-0412","article-title":"Adrenocortical Carcinoma and Pregnancy: Clinical and Biological Features and Prognosis","volume":"163","author":"Abiven-Lepage","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2341","article-title":"Pregnancy in Women Previously Treated for an Adrenocortical Carcinoma","volume":"100","author":"de Corbi\u00e8re","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellbi.2006.11.013","article-title":"Medroxyprogesterone and Tamoxifen Augment Anti-Proliferative Efficacy and Reduce Mitochondria-Toxicity of Epirubicin in FM3A Tumor Cells In Vitro","volume":"31","author":"Altinoz","year":"2007","journal-title":"Cell Biol Int"},{"key":"B24","article-title":"Hormonal Therapy of Human Endometrial Adenocarcinoma in a Nude Mouse Model","volume":"45","author":"Zaino","year":"1985","journal-title":"Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00404-012-2664-0","article-title":"Effect of Tamoxifen, Methoxyprogesterone Acetate and Combined Treatment on Cellular Proliferation and Apoptosis in SKOV3\/DDP Cells Via the Regulation of Vascular Endothelial Growth Factor","volume":"287","author":"Wen","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ygyno.2003.11.014","article-title":"What is the Clinical Value of Adding Tamoxifen to Progestins in the Treatment [Correction for Treament] of Advanced or Recurrent Endometrial Cancer","volume":"92","author":"Herzog","year":"2004","journal-title":"Gynecol Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mce.2003.12.020","article-title":"Adrenocortical Cell Lines","volume":"228","author":"Rainey","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12685","article-title":"Targeting Heterogeneity of Adrenocortical Carcinoma: Evaluation and Extension of Preclinical Tumor Models to Improve Clinical Translation","volume":"7","author":"Hantel","year":"2016","journal-title":"Oncotarget"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110585","article-title":"In Vitro Cytotoxicity of Cabazitaxel in Adrenocortical Carcinoma Cell Lines and Human Adrenocortical Carcinoma Primary Cell Cultures","volume":"498","author":"Fragni","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"B30","volume-title":"Who Classification of Tumours of Endocrine Organs","author":"Lloyd","year":"2017"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2414","article-title":"Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study","volume":"101","author":"Fiorentini","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative Analysis of Dose-Effect Relationships: The Combined Effects of Multiple Drugs or Enzyme Inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"B34","article-title":"Inhibition of Survivin is Associated With Zoledronic Acid-Induced Apoptosis of Prostate Cancer Cells","volume":"36","author":"Fragni","year":"2016","journal-title":"Anticancer Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-016-1224-8","article-title":"The miR-21\/PTEN\/Akt Signaling Pathway is Involved in the Anti-Tumoral Effects of Zoledronic Acid in Human Breast Cancer Cell Lines","volume":"389","author":"Fragni","year":"2016","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2012.11.005","article-title":"Beyond Steroidogenesis: Novel Target Genes for SF-1 Discovered by Genomics","volume":"371","author":"Lalli","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3010","article-title":"MicroRNA23a and microRNA23b Deregulation Derepresses SF-1 and Upregulates Estrogen Signaling in Ovarian Endometriosis","volume":"98","author":"Shen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1823","article-title":"Estrogen Receptor Beta Expression is Associated With Tamoxifen Response in ERalpha-negative Breast Carcinoma","volume":"13","author":"Gruvberger-Saal","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B39","unstructured":"Greenwood Village, Colorado, USAIBM Watson HealthIbm Micromedex\u00ae DRUGDEX\u00ae (Electronic Version)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/me.2006-0337","article-title":"The Role of Extranuclear Signaling Actions of Progesterone Receptor in Mediating Progesterone Regulation of Gene Expression and the Cell Cycle","volume":"21","author":"Boonyaratanakornkit","year":"2007","journal-title":"Mol Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-018-0953-1","article-title":"Reproductive Epidemiology of Glial Tumors may Reveal Novel Treatments: High-Dose Progestins or Progesterone Antagonists as Endocrino-Immune Modifiers Against Glioma","volume":"42","author":"Altinoz","year":"2019","journal-title":"Neurosurg Rev"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1556\/2060.2020.00034","article-title":"The Apoptotic Effects of Progesterone on Breast Cancer (MCF-7) and Human Osteosarcoma (MG-636) Cells","volume":"107","author":"Motamed","year":"2020","journal-title":"Physiol Int"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/en.2018-00831","article-title":"Deciphering Steroid Receptor Crosstalk in Hormone-Driven Cancers","volume":"159","author":"Truong","year":"2018","journal-title":"Endocrinology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1677\/JME-09-0143","article-title":"Adrenocortical Development and Cancer: Focus on SF-1","volume":"44","author":"Lalli","year":"2010","journal-title":"J Mol Endocrinol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1210\/me.2007-0120","article-title":"Increased Steroidogenic Factor-1 Dosage Triggers Adrenocortical Cell Proliferation and Cancer","volume":"12","author":"Doghman","year":"2007","journal-title":"Mol Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3965","article-title":"Towards a Molecular Understanding of MicroRNA-Mediated Gene Silencing","volume":"16","author":"Jonas","year":"2015","journal-title":"Nat Rev Genet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp500","article-title":"Estradiol-Regulated microRNAs Control Estradiol Response in Breast Cancer Cells","volume":"37","author":"Bhat-Nakshatri","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5472","article-title":"Estradiol Induces Apoptosis Via Activation of miRNA-23a and p53: Implication for Gender Difference in Liver Cancer Development","volume":"6","author":"Huang","year":"2015","journal-title":"Oncotarget"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.583","article-title":"Direct Regulation of microRNA Biogenesis and Expression by Estrogen Receptor Beta in Hormone-Responsive Breast Cancer","volume":"31","author":"Paris","year":"2012","journal-title":"Oncogene"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.812438","article-title":"Progesterone Receptor A Promotes Invasiveness and Metastasis of Luminal Breast Cancer by Suppressing Regulation of Critical microRNAs by Estrogen","volume":"293","author":"McFall","year":"2018","journal-title":"J Biol Chem"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.669426\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T11:17:09Z","timestamp":1619435829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.669426\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":50,"alternative-id":["10.3389\/fendo.2021.669426"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.669426","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,26]]},"article-number":"669426"}}